News Focus
News Focus
icon url

EYEBUYSTOX

03/24/14 3:52 PM

#169125 RE: masshysteria #169118

So as someone who lived through Fargo, how do you feel about the company having to issue 100 million more shares while increasing stock and cash bonuses while not disclosing anything as to what happened other than one slide that read, "Clear evidence of dose switching"?

What about breast cancer results that double survival against a historic norm being kept on the shelf for 3 years? Doesn't that upset you while millions suffer? Maybe that's where you should take your high horse and rant first before targeting someone who simply wants to make money and help cancer victims and despises the likes of AF and his crony gang.

You're fighting the wrong battles, sir. And to imply anything I could do or say would have any effect on PPHM stock is simply absurd IMO. Good luck.
icon url

jakedogman1

03/24/14 5:39 PM

#169158 RE: masshysteria #169118

mass ... what is your take on a bod of 4 of which 3 are all tied together, with no biotech experience and bring basically no value to the table. And one could argue the makeup hurts share price (by limiting institutional investors, the ones that due some due diligence). Average makeup of the top 125 biotech companies average over 7 board members and all much more diversified by both experience and relationships. if i can recall, pphm's bod is about 2 standard dev from normal.